A review of treatment and management modalities for premenstrual dysphoric disorder
Kelderhouse, K.; Taylor, J.S.
Nursing for Women's Health 17(4): 294-305
2013
ISSN/ISBN: 1751-486X PMID: 23957795 DOI: 10.1111/1751-486x.12048Document Number: 581831
Premenstrual dysphoric disorder (PMDD) affects 5 to 8 percent of women and can significantly decrease their quality of life. Symptoms generally present during the late luteal phase of the menstrual cycle and can affect women emotionally, behaviorally, cognitively and physiologically. This article reviews the clinical literature on PMDD and the evidence behind various methods of symptom management. Evidence suggests that a holistic approach, including lifestyle modifications, pharmacotherapy and cognitive behavioral therapy, is most beneficial for symptom reduction and improvement in daily functioning and quality of life.